Alzheimer disease: Prostaglandin E2 signalling is implicated in inflammation early in the Alzheimer disease course

@article{Wood2012AlzheimerDP,
  title={Alzheimer disease: Prostaglandin E2 signalling is implicated in inflammation early in the Alzheimer disease course},
  author={Heather Wood},
  journal={Nature Reviews Neurology},
  year={2012},
  volume={8},
  pages={411-411}
}
Prostaglandin E2 (PGE2) signalling via the E-prostanoid 3 (EP3) receptor could be a key component of a toxic inflammatory response that contributes to the development of Alzheimer disease (AD), a new study reported in Annals of Neurology indicates. The researchers, led by Katrin Andreasson at Stanford University School of Medicine, CA, USA, suggest that their findings could assist the discovery of novel preventive strategies for AD. Early clues that prostaglandins might be involved in AD… CONTINUE READING